glutathione kills triple negative cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology A review of biological targets
A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect A photodynamic mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



